Clinical trials
Completed Phase 2 Tuberculosis, Pulmonary trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
48 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 1 |
| 2010 | 4 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 7 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 48 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Global Alliance for TB Drug Development | 8 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 6 |
| Michael Hoelscher | 4 |
| TASK Applied Science | 3 |
| Archivel Farma S.L. | 2 |
| Centers for Disease Control and Prevention | 2 |
| GlaxoSmithKline | 2 |
| Johns Hopkins University | 2 |
| LigaChem Biosciences, Inc. | 2 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tuberculosis, Pulmonary | 48 |
| Tuberculosis | 23 |
| Tuberculosis, Multidrug-Resistant | 4 |
| Extensively Drug-Resistant Tuberculosis | 3 |
| Acquired Immunodeficiency Syndrome | 1 |
| Gram-Positive Bacterial Infections | 1 |
| HIV Infections | 1 |
| Infections | 1 |
| Mycobacterium Infections | 1 |
| Pneumonia | 1 |
Trials
Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.